Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Satoshi Takeuchi

4PUBLICATIONS

17CO-AUTHORS

Solid tumoursRadiation therapyMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 13, 2025

The Biochemical-Imaging Connection: Urinary Noradrenaline and Fluorodeoxyglucose-Positron Emission Tomography in Unresectable or Metastatic Pheochromocytomas and Paragangliomas.

Junki Takenaka, Shiro Watanabe, Takashige Abe

|Feb 26, 2025

Urinary Dopamine Levels Can Predict the Avidity of Post-Therapy [<sup>131</sup>I]MIBG Scintigraphy in Unresectable or Metastatic Pheochromocytomas and Paragangliomas: A Preliminary Clinical Study.

Junki Takenaka, Shiro Watanabe, Takashige Abe

|Jan 17, 2025

Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan.

Takuro Noguchi, Shin Ariga, Rika Moku

|Jul 17, 2023

Early prediction of treatment outcome for lenvatinib using <sup>18</sup>F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study.

Satoshi Takeuchi, Kenji Hirata, Keiichi Magota

Pageof 1

Frequent Collaborators

2 joint publications

Naoto Wakabayashi

2 joint publications

Kohsuke Kudo

2 joint publications

Kenji Hirata

2 joint publications

Shiro Watanabe

2 joint publications

Junki Takenaka

1 joint publications

Rika Moku

1 joint publications

Junko Kikuchi

1 joint publications

Takuya Maeda

1 joint publications

Kosuke Ishikawa

1 joint publications

Kanako Hagio

Frequent Collaborators

2 joint publications

Naoto Wakabayashi

2 joint publications

Kohsuke Kudo

2 joint publications

Kenji Hirata

2 joint publications

Shiro Watanabe

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on : Sep 21, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on : Sep 21, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos